Glucovance, a new tablet that combines glyburide and metformin

September 2000

Bristol-Myers Squibb is now marketing Glucovance, a new tablet that combines glyburide and metformin.

Many patients get metformin and a sulfonylurea for diabetes. These drugs have additive effects to lower blood sugar.

The combination can lower HbA1c by 1.5% to 3.5%...depending on the patient's initial HbA1c.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote